Phase II trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell carcinoma of the head and neck (LA SCCHN): Feasibility and 2-year OS.
Thomas Kuhnt(Leipzig University), Juergen Dunst(Martin Luther University Halle-Wittenberg), Rita Engenhart- Cabilic(Philipps University of Marburg), Peter Hass, Michael Richter, Frank Sieker(Martin Luther University Halle-Wittenberg), A. Pirnasch(University of Rostock), Matthias Hautmann, Andreas Schreiber(University of South Australia), Kathrin Dellas(Martin Luther University Halle-Wittenberg)
Cited by 3
Related Papers
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
|International Journal of Radiation Oncology*Biology*Physics|2000|218